Product Categories
Country: | China |
---|---|
Tel: | |
Mobile: | 17320513646 |
E-mail: | mike@molcoo.com |
QQ: | 3001071511 |
Skype: | Chat Now! |
Address: | Room 005, 15th Floor, Building D2, Phase III, Software New Town, No. 8 Huacheng Avenue, East Lake High-tech Development Zone, Wuhan, Hubei Province, China |
1. Drug standards and drug impurity reference substances: provide more than 20,000 kinds of spot impurity reference substances, with sufficient supply and same-day delivery. We have a professional R&D team and comprehensive quality control testing to ensure product quality and reliability.
2. Customized synthesis of impurities and new molecules: Quickly respond to the customized needs of CDE impurities, stably supply impurities that have established quality standards, and provide customized synthesis services for new compounds in the research and development of innovative drugs.
3. Preparation and separation of unknown impurities: With a professional impurity preparation and separation technical team and SFC preparation and separation instruments, we can solve the problems of impurity preparation in complex projects.
4. Process development of new drug intermediates: provide the supply of new drugs and new molecular impurities, process optimization services, as well as the screening and impurity analysis of commercialization routes.
5. Peptide synthesis: Provide customized peptide synthesis services, and cover all kinds of degradation impurities and process impurities generated in the research and development of peptide drugs. At the same time, it provides comprehensive structural confirmation data and customized testing services.
|
Product Name | MF | CAS | Details |
---|
Irinotecan Impurity HCl | C20H16N2O4 | 110351-92-3 | Details |
D-Fudosteine | C6H13NO3S | 1023971-10-9 | Details |
Resmetirom Impurity | C13H12Cl3N3O | 920509-27-9 | Details |
Fudosteine Impurity | C9H18N2O4S2 | 50727-79-2 | Details |
Prilocaine Impurity | C23H29N3O2 | 2815498-43-0 | Details |
Resmetirom (MGL-3196) | C17H12Cl2N6O4 | 920509-32-6 | Details |
Iopamidol Impurity | 88375-91-1 | Details |
L-Asparagine | C4H8N2O3 | 70-47-3 | Details |
Minoxidil Impurity | C9H14N4O | 1798387-81-1 | Details |
Resmetirom Impurity | C13H13Cl2N3O2 | 920509-28-0 | Details |
Mirtazapine | C17H19N3 | 85650-52-8 | Details |
2-Amino-3-bromobenzaldehyde | C7H6BrNO | 145123-24-6 | Details |
Desloratadine Impurity | C19H19ClN2O | 1193725-73-3 | Details |
Omeprazole Impurity | C7H8N2O3 | 14248-66-9 | Details |
1-Hydroxyindan | C9H10O | 6351-10-6 | Details |
Canagliflozin | C24H25FO5S | 842133-18-0 | Details |
(4-Amino-2-trifluoromethyl-phenyl)-methanol | C8H8F3NO | 900254-46-8 | Details |
Granisetron Impurity HCl | C8H6N2O2 | 4498-67-3 | Details |
Brexpiprazole Impurity | C9H9NO2 | 54197-66-9 | Details |
Moxifloxacin Impurity | C17H18FNO5 | 2489671-14-7 | Details |
Ziprasidone Impurity | C11H13N3S | 87691-87-0 | Details |
Butyphthalide Impurity | C12H12O2 | 551-08-6 | Details |
(S)-Mirtazapine | C17H19N3 | 61337-87-9 | Details |
Mirtazapine Impurity | C17H21N3O | 61337-89-1 | Details |
Mirtazapine Impurity (Mixture of Diastereomers) | C17H19N3O | 155172-12-6 | Details |
N-Nitroso Rasagiline | C12H12N2O | 2470278-90-9 | Details |
Fudosteine Impurity | C6H13NO5S | 1480319-53-6 | Details |
Butyphthalide Impurity | C9H8O2 | 3453-64-3 | Details |
Butyphthalide Impurity | C8H6O4 | 88-99-3 | Details |
Dacotinib monohydrate | C24H27ClFN5O3 | 1042385-75-0 | Details |
Avatrombopag Impurity | C12H13ClN2O4 | 958457-83-5 | Details |
Sitagliptin | C16H15F6N5O | 486460-32-6 | Details |
L-calcium pantothenate | C9H19CaNO5 | 6381-62-0 | Details |
Mirtazapine Impurity(Hydrochloride) | C16H18ClN3 | 1188265-41-9 | Details |
Cefmenoxime Impurity | C14H13N5O5S2 | 66340-33-8 | Details |
Mirtazapine Impurity | C17H21N3 | 191546-94-8 | Details |
Mirtazapine Impurity | C17H17N3O | 191546-97-1 | Details |
Mirtazapine Impurity | C17H18N4 | 61337-88-0 | Details |
Mirtazapine Impurity | C17H17N3O | 191546-96-0 | Details |
Phenylacetaldehyde | C8H8O | 122-78-1 | Details |
rac-Tenofovir | C9H14N5O4P | 107021-12-5 | Details |
Indobufen Impurity | C18H15NO4 | 94232-67-4 | Details |
Rivaroxaban Degradation Impurity | C14H17N3O4.ClH | 898543-06-1 | Details |
Apixaban Impurity | C27H28N4O6 | 1904628-10-9 | Details |
Atorvastatin Impurity | C40H47FN2O5 | 1105067-90-0 | Details |
Rivaroxaban Impurity | C10H13N3O2 | 482308-13-4 | Details |
Lurasidone Impurity | C28H36N4O2S | 194861-74-0 | Details |
Probucol Impurity | C28H42O2 | 128-38-1 | Details |
Aminocaproic Acid Impurity | C12H24N2O3 | 2014-58-6 | Details |
1,3-dihydroxypropan-2-yl 4-hydroxybenzoate | C10H12O5 | 263552-76-7 | Details |
Bromocriptine Impurity | C32H40BrN5O5 | 82796-58-5 | Details |
Rivaroxaban Impurity | C10H12N2O2 | 19532-98-0 | Details |
Rivaroxaban Impurity | C19H18ClN3O5S | 1855920-54-5 | Details |
RivaroxabanImpurity128 | C18H20ClN3O4S | 1325210-62-5 | Details |
Rivaroxaban | C19H18ClN3O5S | 366789-02-8 | Details |
Sitagliptin Impurity | C16H12F6N4O2 | 764667-65-4 | Details |
Rivaroxaban Impurity | C22H19N3O6 | 446292-08-6 | Details |
Regorafenib | C21H15ClF4N4O3 | 755037-03-7 | Details |
Rivaroxaban Impurity | C24H21Cl2N3O7S2 | 1151893-81-0 | Details |
R-Rivaroxaban | C19H18ClN3O5S | 865479-71-6 | Details |
Orforglipron Impurity | C31H33F2N7O3 | 2212022-55-2 | Details |
Oseltamivir Impurity | C13H20O4 | 1234858-94-6 | Details |
Aprepitant Impurity | C23H21F7N4O3 | 1185502-97-9 | Details |
Orforglipron | C48H48F2N10O5 | 2212020-52-3 | Details |
Riociguat Impurity | C22H23FN8O2 | 625115-54-0 | Details |
FurosemideImpurity | C12H10N4O2 | 4329-75-3 | Details |
Pramipexole Impurity HCl | C9H15N3S | 1254579-15-1 | Details |
Ozanimod Impurity | C13H15NO3 | 2098542-97-1 | Details |
Orforglipron Impurity | C23H26N2O2 | 2212021-79-7 | Details |
(S)-3-Hydroxypyrrolidin-2-one | C4H7NO2 | 34368-52-0 | Details |
Linagliptin Impurity | C38H42N10O4 | 2443735-53-1 | Details |
Aprepitant Impurity | C29H25F7N4O3 | 2348441-62-1 | Details |
Aprepitant Impurity | C23H21F7N4O3 | 170902-81-5 | Details |
Aprepitant Impurity | C23H21F7N4O3 | 1242175-34-3 | Details |
Acetylcysteine Impurity | C6H12N2O4S2 | 56-89-3 | Details |
Orforglipron Impurity | C26H25F2N7O | 2212022-56-3 | Details |
Aprepitant Impurity | C21H19F6NO3 | 287930-75-0 | Details |
Imrecoxib Impurity | C12H19NO3S | 479679-98-6 | Details |
Upadacitinib Impurity | C16H21NO4 | 2650489-61-3 | Details |
Orforglipron Impurity | C18H20FN5O | 2212021-62-8 | Details |
Baloxavir Impurity | C14H8F2OS | 2567938-30-9 | Details |
Roxatidine Impurity | C20H33N3O3 | 2905373-89-7 | Details |
Emedastine Impurity | C16H24N4O | 101954-20-5 | Details |
Iodixanol Impurity | C33H41I5N6O14 | 171897-73-7 | Details |
Iodixanol Impurity | C35H43I5N6O15 | 171897-72-6 | Details |
Riociguat Impurity | C19H15FN8O | 1361569-18-7 | Details |
Azilsartan Impurity | C5H10N2O3 | 61445-55-4 | Details |
Baloxavir Impurity | C14H10F2OS | 2496644-37-0 | Details |
Fosfomycin Impurity | C3H9O4P | 76274-77-6 | Details |
Orforglipron Impurity | C25H27N3O2 | 2212021-80-0 | Details |
Baloxavir Impurity | C24H19F2N3O4S | 2571566-81-7 | Details |
Lurasidone Impurity | C28H36N4O3S | 1809325-45-8 | Details |
4,7-Diazaindole | C6H5N3 | 4745-93-1 | Details |
Amlodipine Impurity | C21H25ClN2O5 | 1563063-13-7 | Details |
(R)-Mirtazapine | C17H19N3 | 61364-37-2 | Details |
Trityl trifluoroacetate | C21H15F3O2 | 379-30-6 | Details |
Mirtazapine Impurity | C17H19N3O | 852524-23-3 | Details |
Resmetirom Impurity | C13H13Cl2N3O2 | 2768217-12-3 | Details |
Isavuconazole Impurity | C13H12F2N4O | 2001052-01-1 | Details |
Isavuconazole Impurity | C13H14F2N4OS | 2170932-49-5 | Details |
Product Total: Product Page: | ||||
5 6 7 8 9 10 11 12 13 14 15 16 17 18 19 20 21 22 23 24 25 26 27 28 29 30 31 32 33 34 35 36 37 38 39 40 41 42 43 44 45 46 47 48 49 50 51 52 53 54 55 56 57 58 59 60 61 62 63 64 65 66 67 68 69 70 71 72 73 74 75 76 77 78 79 80 81 82 83 84 85 86 87 88 89 90 91 92 93 94 95 96 97 98 99 |